Peripheral B‐cell dysregulation is associated with relapse after long‐term quiescence in patients with multiple sclerosis

B cells play a major role in multiple sclerosis (MS), with many successful therapeutics capable of removing them from circulation. One such therapy, alemtuzumab, is thought to reset the immune system without the need for ongoing therapy in a proportion of patients. The exact cells contributing to di...

Descripción completa

Detalles Bibliográficos
Autores principales: Marsh‐Wakefield, Felix, Juillard, Pierre, Ashhurst, Thomas M, Juillard, Annette, Shinko, Diana, Putri, Givanna H, Read, Mark N, McGuire, Helen M, Byrne, Scott N, Hawke, Simon, Grau, Georges E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322415/
https://www.ncbi.nlm.nih.gov/pubmed/35416319
http://dx.doi.org/10.1111/imcb.12552

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322415/
https://www.ncbi.nlm.nih.gov/pubmed/35416319
http://dx.doi.org/10.1111/imcb.12552

Ejemplares similares